Recent Finacing
Recent Raise
Intrepida Bio is a San Diego biotech developing monoclonal antibodies against BAG3 and IFITM-2 to modulate the tumor-supportive microenvironment and advance oncology candidates toward IND.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Intrepida Bio.
